BioMarin Pharmaceuticals
BMRN
BMRN
466 hedge funds and large institutions have $14.7B invested in BioMarin Pharmaceuticals in 2019 Q4 according to their latest regulatory filings, with 81 funds opening new positions, 181 increasing their positions, 133 reducing their positions, and 45 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more capital invested
Capital invested by funds: $ → $
more funds holding in top 10
Funds holding in top 10: →
7% more funds holding
Funds holding: 435 → 466 (+31)
6% more call options, than puts
Call options by funds: $156M | Put options by funds: $147M
0.32% less ownership
Funds ownership: 96.92% → 96.6% (-0.32%)
Holders
466
Holding in Top 10
10
Calls
$156M
Puts
$147M
Top Buyers
| 1 | +$371M | |
| 2 | +$110M | |
| 3 | +$98.7M | |
| 4 |
Westfield Capital Management
Boston,
Massachusetts
|
+$43.8M |
| 5 |
Balyasny Asset Management
Chicago,
Illinois
|
+$40.4M |
Top Sellers
| 1 | -$375M | |
| 2 | -$138M | |
| 3 | -$135M | |
| 4 |
Viking Global Investors
Stamford,
Connecticut
|
-$121M |
| 5 |
Jennison Associates
New York
|
-$109M |